INDT

253.4

+7.83%↑

CAST

126.9

+1.12%↑

PNDX.B

196.8

+1.55%↑

WALL.B

43.3

+0.65%↑

SAGAD

34.75

+0.72%↑

INDT

253.4

+7.83%↑

CAST

126.9

+1.12%↑

PNDX.B

196.8

+1.55%↑

WALL.B

43.3

+0.65%↑

SAGAD

34.75

+0.72%↑

INDT

253.4

+7.83%↑

CAST

126.9

+1.12%↑

PNDX.B

196.8

+1.55%↑

WALL.B

43.3

+0.65%↑

SAGAD

34.75

+0.72%↑

INDT

253.4

+7.83%↑

CAST

126.9

+1.12%↑

PNDX.B

196.8

+1.55%↑

WALL.B

43.3

+0.65%↑

SAGAD

34.75

+0.72%↑

INDT

253.4

+7.83%↑

CAST

126.9

+1.12%↑

PNDX.B

196.8

+1.55%↑

WALL.B

43.3

+0.65%↑

SAGAD

34.75

+0.72%↑

Home・Aandelen Lijst・JM AB

J
JM AB

Gesloten

122.2 2.43

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

121.6

Max

122.4

Belangrijke statistieken
By Trading Economics
Inkomsten	10M -23M
Verkoop	546M 2.9B
K/W Sectorgemiddelde	138.851 56.537
EPS	-0.32
Dividendrendement	1.65
Winstmarge	-0.806
Werknemers	1,830
EBITDA	-30M 6M

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	1.65% 6.48%
Volgende Winsten	23 apr 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-1.2B 7.8B
Vorige openingsprijs	119.77
Vorige sluitingsprijs	122.2

JM AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 apr 2026, 20:26 UTC

Acquisities, Fusies, Overnames

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17 apr 2026, 18:15 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17 apr 2026, 16:49 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

18 apr 2026, 01:00 UTC

Belangrijke Nieuwsgebeurtenissen

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 apr 2026, 22:58 UTC

Winsten

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 apr 2026, 21:32 UTC

Marktinformatie

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

17 apr 2026, 21:22 UTC

Marktinformatie

Moody's Downgrades Belgium to A1 -- Market Talk

17 apr 2026, 20:52 UTC

Winsten

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 apr 2026, 20:50 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

17 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

17 apr 2026, 20:29 UTC

Winsten

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17 apr 2026, 20:11 UTC

Acquisities, Fusies, Overnames

UCB to Buy Neurona Therapeutics for Up to $1.15B

17 apr 2026, 19:34 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Global Equities Roundup: Market Talk

17 apr 2026, 19:34 UTC

Marktinformatie

Winsten

Acquisities, Fusies, Overnames

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17 apr 2026, 19:31 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17 apr 2026, 19:26 UTC

Marktinformatie

U.S. Natural Gas Futures Edge Up -- Market Talk

17 apr 2026, 19:21 UTC

Marktinformatie

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17 apr 2026, 19:15 UTC

Marktinformatie

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 apr 2026, 19:07 UTC

Marktinformatie

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 apr 2026, 18:57 UTC

Belangrijke Nieuwsgebeurtenissen

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17 apr 2026, 18:53 UTC

Acquisities, Fusies, Overnames

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17 apr 2026, 18:53 UTC

Acquisities, Fusies, Overnames

UCB 2026 Rev Guidance Unchanged

17 apr 2026, 18:52 UTC

Acquisities, Fusies, Overnames

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17 apr 2026, 18:52 UTC

Acquisities, Fusies, Overnames

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17 apr 2026, 18:14 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17 apr 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17 apr 2026, 18:00 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17 apr 2026, 17:31 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17 apr 2026, 17:26 UTC

Marktinformatie

Winsten

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Peer Vergelijking

Prijswijziging

JM AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over JM AB

JM AB (publ) develops and sells housing and residential areas in the Nordic region. The company operates JM Residential Stockholm, JM Residential Sweden, JM Norway, JM Finland, JM Property Development, and JM Construction segments. It also engages in the acquisition of development properties; planning, pre-construction, production, and sale of residential units; development of rental units, residential care units, and commercial properties; and contract works primarily in the Greater Stockholm area. The company was incorporated in 1945 and is headquartered in Solna, Sweden.